1. What Strattera is
Strattera is the brand name for atomoxetine, approved by the FDA in 2002 as the first non-stimulant treatment for ADHD. It broke a monopoly: until then, treating ADHD meant a controlled substance or nothing. It has since gone generic, which means atomoxetine is now among the cheapest ADHD medications available — a fact that matters far more in real decisions than most clinical write-ups admit.
“Non-stimulant” is doing two separate jobs in that sentence, and they are worth separating. Pharmacologically, atomoxetine does not act like amphetamine or methylphenidate. Administratively, it carries no DEA schedule — no monthly prescription that cannot be refilled, no pharmacy shortage roulette, nothing to misuse, and none of the low-grade suspicion that adults on stimulants learn to expect at a counter.
2. How it works
Atomoxetine is a selective norepinephrine reuptake inhibitor. It blocks the transporter that reabsorbs norepinephrine after release, so more of it stays in the synapse — and the effect is concentrated where ADHD lives, in the prefrontal cortex that runs attention, working memory and impulse control.
There is an elegant wrinkle here that explains almost everything else about the drug. In the prefrontal cortex, dopamine is cleared largely by that samenorepinephrine transporter. So blocking it raises prefrontal dopamine as well — exactly where you want it — while leaving the striatal reward circuitry, where dopamine surges produce euphoria and reinforce misuse, essentially untouched. That single anatomical quirk is why atomoxetine improves ADHD symptoms without producing a high, without abuse potential, and without a schedule.
It is also why it never feels like anything. There is no moment when it arrives. Adults switching from a stimulant routinely misread this as the drug not working, when what has actually changed is that they are no longer feeling a dose land. The question to ask after six weeks is not “can I feel it?” but “is my life going better than it was?” — and the people who live with you are often better placed to answer that than you are.
3. How long it takes — the six-week problem
Some improvement may appear within a couple of weeks. Full effect takes roughly four to eight weeks, and sometimes longer. This is the most important fact on this page, and it is routinely delivered as a throwaway line at the end of an appointment.
Look honestly at what is being asked. You are telling someone whose nervous system is specifically poor at sustaining unrewarded effort towards a delayed and uncertain payoff to take a daily pill that does nothing perceptible, through a stretch of nausea and fatigue, on the promise that something might happen a month and a half from now. That is close to a purpose-built executive-function trap. People do not abandon atomoxetine because it failed them. They abandon it because the waiting did.
Three things genuinely help. Set the trial length before you start, write it somewhere you will actually see it in week three, and treat that date as the decision point rather than re-opening the question every morning. Take it with food from day one, because the early nausea ends more trials than the wait does. And enlist an outside observer — a partner, a friend, a colleague — because a gradual, unfelt improvement is far easier to see from the outside than the inside. If you are going to give this drug six weeks, give it six weeks with the conditions that let it succeed.
4. Dosing (and never open the capsule)
Adults generally start around 40 mg once daily, increase after at least three days to a target of about 80 mg daily, and may go to a maximum of 100 mg after a further two to four weeks if the response is inadequate. Children and adolescents under roughly 70 kg are dosed by body weight rather than by fixed milligrams. It can be taken as a single daily dose or split into two — some people find a split dose easier on the stomach, and some find an evening component helps them sleep.
Two practical points matter more than they look. First: take it with food. It works perfectly well on an empty stomach, but the nausea that ends so many atomoxetine trials is dramatically reduced by food, and that alone can be the difference between completing the trial and quitting in week two. Second, and specifically: never open the capsule.The contents are an eye irritant. Unlike some ADHD medications, this one cannot be sprinkled onto food — it must be swallowed whole. If the powder does reach an eye, flush it with water immediately and seek advice.
5. Side effects, including the ones adults aren’t told
The common ones: nausea — the headline complaint, worst early, much better with food — along with dry mouth, reduced appetite, fatigue or sleepiness, insomnia, dizziness and constipation. Modest rises in heart rate and blood pressure can occur and are worth monitoring if you already have cardiovascular concerns.
Then there are the ones adults are frequently not warned about, and which people are often embarrassed to raise. Sexual side effects are common in adults on atomoxetine— reduced libido, erectile dysfunction, and difficulty with ejaculation. So is urinary hesitancy: difficulty starting to urinate, a weaker stream, a sense of incomplete emptying. These are known, documented effects of the drug, not something wrong with you and not something you have imagined.
They are worth naming plainly because silence about them causes real harm. People quietly stop a medication that was helping and tell their prescriber it “just didn’t work,” because the actual reason felt impossible to say out loud. Say it out loud. It is a known side effect of a drug, it is dose-related for some people, and a prescriber who has heard it a thousand times can only help you if they know.
6. The two serious warnings
The boxed warning: suicidal ideation.Atomoxetine carries a boxed warning for suicidal thoughts in children and adolescents. It demands real monitoring rather than either panic or dismissal: anyone starting it — above all a young person — should be watched closely in the early weeks and at every dose change, and any new or worsening thoughts of self-harm, agitation, or an unfamiliar darkening of mood should be reported to the prescriber straight away rather than waited out. Tell someone you live with that you are starting it and what to watch for. That costs nothing and it is exactly what the warning is asking for.
If you are having thoughts of harming yourself, please contact your prescriber, your local emergency number, or a crisis line now. In the US you can call or text 988. In the UK and Ireland, Samaritans is on 116 123. You deserve support, and this is not something to sit with alone.
Rare liver injury. Severe liver injury is rare but real with atomoxetine, and it is the reason a specific set of symptoms should never be waited out: yellowing of the skin or eyes, unusually dark urine, persistent right-upper-abdominal pain, unexplained itching, or a flu-like illness that arrives without a flu. Any of those warrants stopping the medication and contacting your prescriber promptly. Rare does not mean hypothetical, and this one is genuinely worth memorising.
7. Weight loss and appetite
Reduced appetite is common, and modest weight loss in the early months is a frequent effect — usually less pronounced than with stimulants, and often stabilising after the first few months as appetite partially returns.
It is a side effect, not a feature. Atomoxetine is not a weight-loss drug, should never be taken as one, and the appetite suppression is worth watching rather than welcoming: chronic under-eating makes fatigue worse, makes concentration worse, and undermines the very thing you took the medication to improve. If the weight loss is significant or continuing, that is a prescriber conversation. In children it is one of the specific things a paediatrician tracks, because growth is not negotiable.
8. Alcohol, and the “foods to avoid” question
Alcohol. There is no major established pharmacokinetic interaction between atomoxetine and alcohol, and moderate drinking is not formally forbidden. But two cautions are real: atomoxetine carries that rare liver-injury risk and alcohol is itself hard on the liver, so heavy or regular drinking is a genuinely poor pairing; and sedation and dizziness can compound. An occasional drink is not usually a crisis. Heavy drinking is a real concern. This is worth raising honestly with your prescriber rather than guessing at, and honesty here costs you nothing you should be afraid of losing.
Foods to avoid.A great many people search for this list, so here is the honest answer: there isn’t one. There is no grapefruit rule, no tyramine restriction, no forbidden category. You can take atomoxetine with or without food, and taking it withfood is actively helpful because it blunts the nausea. The thing people are really reaching for when they ask this question is a real concern — “what could interfere with my medication?” — and the answer to that question is not food. It is other drugs.
9. CYP2D6 — the interaction that actually matters
Atomoxetine is metabolised by the liver enzyme CYP2D6, and two facts follow from that.
First, people differ genetically in how much CYP2D6 activity they have. A minority are “poor metabolisers” who clear the drug slowly and end up with substantially higher blood levels from the same dose — which usually means more side effects, sometimes considerably more. If you reacted to a standard starting dose as though it were an enormous one, that is a real phenomenon with a real name, not you being dramatic, and it is worth saying to your prescriber in those words.
Second, other drugs that inhibit CYP2D6 do the same thing chemically. That includes several very commonly co-prescribed antidepressants — fluoxetine and paroxetine among them — which is not a rare combination, given how often ADHD and depression travel together. The result is the same: higher atomoxetine levels, more side effects, from a dose that looks unremarkable on paper. This is precisely why the boring instruction matters. Give your prescriber and your pharmacist the complete list of what you take, including the things you do not think of as medication.
10. Strattera vs Adderall, Qelbree and Wellbutrin
vs Adderall (and stimulants generally). These are not really competing for the same job. Stimulants work in an hour, have a larger average effect on core symptoms, and come with a peak, a wear-off, appetite and sleep costs, and a controlled-substance apparatus. Atomoxetine works over weeks, has a smaller average effect, and has none of that apparatus: no crash, no rebound, continuous coverage that is still there at 7am with the children and at 9pm when your patience has run out, no monthly script, nothing to misuse. If you can take a stimulant and tolerate it, one is usually tried first, and that is reasonable. Atomoxetine becomes the better answer when stimulants are unavailable, unsuitable, or when their costs outweigh their larger effect.
vs Qelbree (viloxazine).The closest comparison, and the one most worth thinking about. Both are once-daily non-stimulants raising norepinephrine signalling; neither is scheduled. Qelbree typically shows something within a week or two, against atomoxetine’s six-plus — for many people that difference alone decides it. Qelbree adds serotonergic activity; atomoxetine is essentially a pure norepinephrine reuptake inhibitor. Their interaction problems run in opposite directions: atomoxetine is a CYP2D6 substrate (other drugs raise its levels), while Qelbree is a CYP1A2 inhibitor(it raises the levels of other things, caffeine included). Atomoxetine carries the liver warning; both carry the suicidality boxed warning. And atomoxetine is generic and cheap while Qelbree usually is not — which, unglamorously and honestly, is what decides this for a great many people. See our full Qelbree guide.
vs Wellbutrin (bupropion). Bupropion is used off-label for ADHD and acts on both norepinephrine and dopamine, which makes it the non-stimulant closest in mechanism to a stimulant. It is often chosen when depression sits alongside ADHD, since it treats both. It lowers the seizure threshold, which rules it out for some people. Atomoxetine has the formal ADHD approval and the better ADHD evidence base; bupropion has the dual action. See our Wellbutrin guide.
One thing worth holding onto through all of these comparisons: failing one of these medications does not predict failing the others. People who got nothing from atomoxetine sometimes respond well to viloxazine, and vice versa. A disappointing first trial is information, not a verdict.
11. Who Strattera genuinely suits
- Adults for whom stimulants are off the table— cardiovascular concerns, intolerable anxiety on stimulants, or a substance-use history that makes a Schedule II prescription a poor idea. Atomoxetine has nothing to misuse.
- ADHD with prominent anxiety. Stimulants sometimes sharpen anxiety; atomoxetine generally does not, and often helps it.
- ADHD with tics. It does not tend to worsen them the way stimulants sometimes can.
- People for whom the evenings are the problem.A stimulant covers a working day. Atomoxetine is simply present — including for the bedtime routine, the 6pm homework, the hour when everything falls apart.
- People for whom the pharmacy is the problem. Monthly controlled-substance prescriptions and repeated stimulant shortages are an executive-function tax levied on exactly the people least able to pay it. A non-scheduled generic removes it entirely.
- People for whom cost is decisive. Generic atomoxetine is cheap. That is not a small consideration; for many people it is the whole consideration, and there is no shame in it.
12. FAQ
Is Strattera a stimulant?
No. Strattera (atomoxetine) was the first non-stimulant approved for ADHD, licensed by the FDA in 2002, and it is not a controlled substance. It has no recognised abuse potential, produces no acute 'switch-on' effect, and creates no rebound or crash as it wears off — because there is no peak to come down from. The trade-off is that it does nothing perceptible on day one. It builds over weeks, and its average effect on core ADHD symptoms is smaller than that of stimulant medication.
How does Strattera work?
Atomoxetine is a selective norepinephrine reuptake inhibitor. It blocks the transporter that reabsorbs norepinephrine, raising noradrenergic signalling — particularly in the prefrontal cortex, the region running attention, working memory and impulse control. Notably, in the prefrontal cortex that same transporter also clears dopamine, so blocking it raises dopamine there too, while leaving the reward-related dopamine circuits of the striatum largely untouched. That selectivity is the pharmacological reason atomoxetine has no euphoria, no abuse potential and no schedule attached — and also why it never delivers the acute lift a stimulant does.
How long does Strattera take to work?
Longer than almost anyone is warned. Some improvement can appear within a couple of weeks, but the accepted window for full effect is roughly 4 to 8 weeks, and some people take longer still. This is the single most important fact about the medication, because the mismatch between that timeline and an ADHD nervous system — which is specifically poor at persisting through an unrewarding effort towards a delayed, uncertain payoff — is why so many people abandon a drug that would have worked for them. Decide your trial length in advance, write it down, and judge it on whether your weeks are going better rather than on whether you can feel a pill.
What are the side effects of Strattera?
Common: nausea (especially early, and much better if taken with food), dry mouth, reduced appetite, fatigue or sleepiness, insomnia, dizziness, and constipation. In adults specifically, sexual side effects are common and under-discussed — reduced libido, erectile dysfunction and problems with ejaculation — as is urinary hesitancy or difficulty starting to urinate. Modest increases in heart rate and blood pressure can occur. Two serious but rare things to know about: a boxed warning for suicidal thoughts in children and adolescents, and rare liver injury — jaundice, dark urine, unexplained flu-like illness or right-upper-abdominal pain warrant stopping and contacting your prescriber immediately.
What is the usual Strattera dose?
Adults typically start around 40 mg once daily, then increase after at least three days to a target of about 80 mg daily, with a possible further increase to a maximum of 100 mg after another two to four weeks if needed. Children and adolescents under about 70 kg are dosed by weight rather than by fixed milligrams. It can be taken once daily or split into two doses, and it works fine with or without food — though taking it with food substantially reduces the nausea that ends many trials. One specific warning: the capsule must be swallowed whole and never opened, because the contents are an eye irritant. If the powder does contact an eye, flush with water immediately. Your prescriber sets your dose; these are the standard patterns, not a recommendation.
Does Strattera cause weight loss?
It commonly reduces appetite, and modest weight loss is a frequent early effect — usually smaller than with stimulants and often stabilising after the first few months. It is a side effect, not a purpose: atomoxetine is not a weight-loss drug and should never be taken as one. If weight loss is significant, ongoing, or unwanted, that is a prescriber conversation rather than something to push through. In children it is one of the specific things a paediatrician monitors, because growth matters more than a number on a scale.
Can you drink alcohol on Strattera?
There is no major established pharmacokinetic interaction between atomoxetine and alcohol, and moderate drinking is not formally prohibited — but two things deserve genuine caution. Atomoxetine carries a rare risk of liver injury, and alcohol is itself hard on the liver, so heavy or regular drinking is a poor combination. And sedation and dizziness can compound. The honest answer is that an occasional drink is not usually a crisis, heavy drinking is a real concern, and this is a conversation worth having openly with your prescriber rather than guessing at.
Are there foods to avoid on Strattera?
Genuinely, no — and it is worth saying plainly, because this is one of the most-searched questions about the drug and the honest answer is short. There is no list of forbidden foods, no grapefruit rule, no tyramine restriction. You can take it with or without food, and taking it with food tends to reduce nausea rather than cause problems. What actually matters is not food but medication: atomoxetine is metabolised by the liver enzyme CYP2D6, so drugs that inhibit it — including some common antidepressants such as fluoxetine and paroxetine — can raise your atomoxetine levels substantially. Give your prescriber a complete list of everything you take.
Strattera vs Adderall — which is better?
They are not really competing for the same job. Adderall is a stimulant: it works within an hour, has a larger average effect on core ADHD symptoms, and is a controlled substance with a peak, a wear-off, and appetite and sleep costs. Strattera works over weeks, has a smaller average effect, and is not scheduled — no monthly prescription, no pharmacy shortages, no abuse potential, no crash, and continuous coverage that is still present at 7am and at 9pm rather than only across a working day. If you can take a stimulant and tolerate it, it is usually tried first for good reason. Strattera becomes the better choice when stimulants are unavailable, unsuitable, or when their costs — the crash, the appetite, the anxiety, the controlled-substance apparatus — outweigh their larger effect.
Strattera vs Qelbree — what's the difference?
Both are once-daily non-stimulants that raise norepinephrine signalling, and neither is a controlled substance. The practical differences: Qelbree usually shows something within a week or two, while Strattera commonly takes six weeks or more — for many people that alone decides it. Qelbree adds serotonergic activity; Strattera is essentially a pure norepinephrine reuptake inhibitor. Strattera is cleared by CYP2D6 (so poor metabolisers get much higher exposure), whereas Qelbree inhibits CYP1A2 and therefore raises the levels of other things, caffeine included. Strattera carries the rare liver-injury warning; both carry the suicidality boxed warning. And Strattera has been generic for years, so it is usually far cheaper — which, honestly, is what settles this comparison for a great many people.